玻尿素毒素A对白发作患者的持续抗焦虑和抗抑郁作用超出了运动症状控制的范围
Xin-Yi He1, Min-Ye Xu1, Li-Ying Feng1
1Department of Geriatrics, Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.
World journal of psychiatry
|January 29, 2026
概括
重复注射肉毒素A (BoNT-A) 在白发作患者的焦虑和抑郁症中提供了持久的缓解,即使在运动症状改善后消失. 这表明BoNT-A提供了超越其主要治疗效果的持续情绪益处.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 眼科医生 眼科 眼科
背景情况:
- 之前对白发作中的肉毒素A (BoNT-A) 的研究集中在峰值运动症状缓解期间的作用上.
- 面部反假说指导了对BoNT-A对白发作患者情绪影响的研究.
研究的目的:
- 为了研究BoNT-A在白发作患者中持久的抗焦虑和抗抑郁作用.
- 评估BoNT-A的好处是否超出了运动症状的控制范围.
主要方法:
- 分析了接受BoNT-A治疗的良性基本白发作患者.
- 詹科维奇评分表,白发作残疾指数,SAS,SDS,HAMA和HAM-D分数在治疗前和再注射前进行了比较.
- 进行了分组分析,以评估重复BoNT治疗的效果.
主要成果:
- 自评抑郁量表 (SDS) 和自评焦虑量表 (SAS) 的分值在一次BoNT-A注射后显著降低.
- 每次额外的BoNT-A注射都将中度抑郁症状的几率比率降低了92.6%.
- 重复的BoNT-A注射维持了降低的SDS和SAS分数,表明持续的情绪改善.
结论:
- 重复的BoNT-A注射为白发作中的焦虑和抑郁症状提供了长期的缓解.
- 即使运动症状效应减弱时,BoNT-A的情绪调节效应仍然存在.
- BoNT-A显示出作为治疗选择的潜力,用于治疗白发作中的运动和情绪障碍.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.2K
Hierarchy of Motor Control
6.2K
The hierarchy of motor control refers to the different levels of organization and processing involved in controlling movement in the body. These levels range from higher cortical areas involved in planning and decision-making to lower spinal cord reflexes that respond automatically to external stimuli.
6.2K
Sustainable Development
15.1K
As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
15.1K
Anxiolytic Drugs: Overview
1.2K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.2K
Pharmacodynamics in Geriatric Patients: Effects of Age
234
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
234
Antidepressant Drugs: Overview
1.5K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.5K


